Jim Cramer's latest portfolio includes Pfizer Inc. as the 3rd top stock to buy. Cramer emphasizes the importance of recession-proof stocks amid aggressive rate cuts. Pfizer's potential growth catalysts and cost-cutting efforts make it a promising long-term investment.